Oxford University this morning announced more promising news in the development of its COVID-19 vaccine.
The results from Phase 2 of its AZD122 vaccine trial, published in the Lancet on Thursday, show that the vaccine is as effective for the older demographic as it is for the younger.
Story: https://wfts.tv/3pM5mAe